BLUE JET HEALTHCARE Financial Statement Analysis
|
||
|
The Revenues of BLUE JET HEALTHCARE have increased by 5.49% YoY .
The Earnings Per Share (EPS) of BLUE JET HEALTHCARE has increased by 2.28 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
BLUE JET HEALTHCARE Last 5 Annual Financial Results
[BOM: 544009|NSE : BLUEJET]
| Standalone | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|
| Revenues | ₹721 Cr | ₹683 Cr | ₹499 Cr | ₹499 Cr |
| Expenses | ₹502 Cr | ₹434 Cr | ₹292 Cr | ₹292 Cr |
| Operating Profit (Excl OI) | ₹219 Cr | ₹249 Cr | ₹207 Cr | ₹207 Cr |
| Other Income | ₹24 Cr | ₹19 Cr | ₹8.61 Cr | ₹8.61 Cr |
| Interest | ₹1.36 Cr | ₹3.30 Cr | ₹5.31 Cr | ₹5.31 Cr |
| Depreciation | ₹25 Cr | ₹22 Cr | ₹20 Cr | ₹20 Cr |
| Profit Before Tax | ₹217 Cr | ₹243 Cr | ₹190 Cr | ₹190 Cr |
| Profit After Tax | ₹160 Cr | ₹182 Cr | ₹142 Cr | ₹142 Cr |
| Earnings Per Share (Rs) | ₹9.44 | ₹9.23 | ₹10.47 | ₹1,428.73 |
| PAT Margin (%) | 23.01 | 22.20 | 26.57 | 28.38 |
| ROE(%) | 21.45 | 26.60 | 42.16 | 41.67 |
| ROCE(%) | 28.85 | 36.24 | 54.01 | 50.03 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.15 |
Key Financials |
||
| Market Cap | : | ₹ 14,414.4 Cr |
| Revenue (TTM) | : | ₹ 873.5 Cr |
| Net Profit(TTM) | : | ₹ 234.8 Cr |
| EPS (TTM) | : | ₹ 13.5 |
| P/E (TTM) | : | 61.4 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| BLUE JET HEALTHCARE | 9.8% | 42.5% | 138.8% |
| SUN PHARMACEUTICAL INDUSTRIES | -0% | -4.6% | 18.9% |
| CIPLA | 2.4% | -1.1% | 0.8% |
| DR REDDYS LABORATORIES | 2.6% | -9.9% | -0.4% |
| ZYDUS LIFESCIENCES | 3.6% | -0.1% | 22.7% |
| DIVIS LABORATORIES | 8.8% | 5.1% | 64.4% |
| MANKIND PHARMA | -0.1% | -12.4% | 18.5% |
| TORRENT PHARMACEUTICALS | -1.4% | -4.9% | 19.3% |
| LUPIN | 6.4% | -2.9% | 38.4% |
BLUE JET HEALTHCARE Revenues
[BOM: 544009|NSE : BLUEJET]
| Y-o-Y | 5.49 % |
| 5 Yr CAGR | 13.06 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹721 Cr | 5.49 | |
| Mar2023 | ₹683 Cr | 36.99 | |
| Mar2022 | ₹499 Cr | 0.00 | |
| Mar2021 | ₹499 Cr | - | |
BLUE JET HEALTHCARE Operating Profit
[BOM: 544009|NSE : BLUEJET]
| Y-o-Y | -12.11 % |
| 5 Yr CAGR | 1.93 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹219 Cr | -12.11 | |
| Mar2023 | ₹249 Cr | 20.50 | |
| Mar2022 | ₹207 Cr | 0.00 | |
| Mar2021 | ₹207 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -16.67 % |
| 5 Yr CAGR | -9.84 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 30.39% | -16.67 | |
| Mar2023 | 36.47% | -12.04 | |
| Mar2022 | 41.46% | 0.00 | |
| Mar2021 | 41.46% | - | |
BLUE JET HEALTHCARE Profit After Tax
[BOM: 544009|NSE : BLUEJET]
| Y-o-Y | -11.88 % |
| 5 Yr CAGR | 4.16 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹160 Cr | -11.88 | |
| Mar2023 | ₹182 Cr | 28.23 | |
| Mar2022 | ₹142 Cr | 0.00 | |
| Mar2021 | ₹142 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 3.65 % |
| 5 Yr CAGR | -6.75 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 23.01 % | 3.65 | |
| Mar2023 | 22.2 % | -16.45 | |
| Mar2022 | 26.57 % | -6.38 | |
| Mar2021 | 28.38 % | - | |
BLUE JET HEALTHCARE Earnings Per Share (EPS)
[BOM: 544009|NSE : BLUEJET]
| Y-o-Y | 2.28 % |
| 5 Yr CAGR | -81.24 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹9.44 | 2.28 | |
| Mar2023 | ₹9.23 | -11.84 | |
| Mar2022 | ₹10 | -99.27 | |
| Mar2021 | ₹1,429 | - | |
BLUE JET HEALTHCARE Return on Capital Employed (ROCE)
[BOM: 544009|NSE : BLUEJET]
| Y-o-Y | -20.39 % |
| 5 Yr CAGR | -16.77 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 28.85% | -20.39 | |
| Mar2023 | 36.24% | -32.90 | |
| Mar2022 | 54.01% | 7.96 | |
| Mar2021 | 50.03% | - | |
BLUE JET HEALTHCARE Share Price vs Sensex
| Current Share Price | : | ₹830.8 |
| Current MarketCap | : | ₹ 14,414.4 Cr |
| Updated EOD on | : | Feb 06,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLUE JET HEALTHCARE | 9.8% |
42.5% |
138.8% |
| SENSEX | 0.7% |
-0.1% |
8.8% |
BLUE JET HEALTHCARE related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE HEALTHCARE | 3.2% | -4.3% | 26.2% |
| S&P BSE ALLCAP | 2.3% | -2.9% | 9.2% |
| S&P BSE SMALL CAP | 1.1% | -7.6% | 10.4% |
| S&P BSE MIDSMALLCAP | 0.5% | -6.8% | 10.5% |
No NSE index found
You may also like the below Video Courses
FAQ about BLUE JET HEALTHCARE Financials
How the annual revenues of BLUE JET HEALTHCARE have changed ?
The Revenues of BLUE JET HEALTHCARE have increased by 5.49% YoY .
How the Earnings per Share (EPS) of BLUE JET HEALTHCARE have changed?
The Earnings Per Share (EPS) of BLUE JET HEALTHCARE has increased by 2.28 % YoY .
Check out Intrinsic Value of Peers of BLUE JET HEALTHCARE
Compare Stock Analytics of Peers of BLUE JET HEALTHCARE
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
